| 摘要 |
<p>This invention relates to novel 5-[3-aryl-prop-2-ynyl]-5- -(arylsulfonyl)-thiazolidine-2,4-diones and 5-[3-aryl-prop- -2-ynyl]-5-(arylsulfanyl)thiazolidine-2,4-diones characterised by general formula (I), wherein Ar is phenyl, 2-naphthyl, alkyl substituted phenyl, alkoxy substituted phenyl, halogen substituted phenyl, 2-pyridinyl, substituted 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 2-quinolinyl, 2-pyrimidinyl, 2-benzoxazolyl, 2-benzthiazolyl, 2-benzimidazolyl, 2-furanyl, 2-benzo-[b]-furanyl, 2-thienyl, 2 -benzo-[b]-thienyl; n is 0 or 2; and Ar' is phenyl, alkyl substituted phenyl, perfluoroalkyl substituted phenyl, halogen substituted phenyl, alkoxy substituted phenyl, perfluoroalkoxy substituted phenyl and alkylthio substituted phenyl. This invention also relates to the use of the above mentioned compounds in lowering the blood glucose levels in hyperglycemic mammals and pharmaceutical compositions containing the same.</p> |
